Full report (PDF)
Financial report (PDF)
22.8%
Revenue up
Electronic prescription in Germany
Ban on Rx mail-order included in the coalition agreement
5.5%
200
Mio.
in net proceeds
Expansion of business model to include marketplace PromoFarma – springboard for further international expansion
72.5%
OTC sales growth in Germany
Bond for115 million successfully placed
Paper prescription as an impediment to growth in Rx business
from 18 to
31%
Acquisition of apo-rot, medpex and PromoFarma
